Coenzyme Q10 and nicotinamide and a free radical spin trap protect against MPTP neurotoxicity

Mitochondrial Complex I Deficiency in Parkinson's Disease

Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283 · see citing works

Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.

Javitch, J. A., D’Amato, R. J., Strittmatter, S. M., & Snyder, S. H. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.7.2173 · Cited by 1,264 · see citing works

Nitric Oxide Activation of Poly(ADP-Ribose) Synthetase in Neurotoxicity

Zhang, J., Dawson, V. L., Dawson, T. M., & Snyder, S. H. (1994) · Science · doi:10.1126/science.8080500 · Cited by 1,118 · see citing works

Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?

Beal, M. F. (1992) · Annals of Neurology · doi:10.1002/ana.410310202 · Cited by 956 · see citing works

Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations.

Frei, B. B., Kim, M. C., & Ames, B. N. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.12.4879 · Cited by 623 · see citing works

Advances in Our Understanding of the Mechanisms of the Neurotoxicity of MPTP and Related Compounds

Tipton, K. F., & Singer, T. P. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb13610.x · Cited by 540 · see citing works

Spontaneous Kearns-Sayre/chronic external ophthalmoplegia plus syndrome associated with a mitochondrial DNA deletion: a slip-replication model and metabolic therapy.

Shoffner, J. M., Lott, M. T., Voljavec, A. S., Soueidan, S. A., Costigan, D. A., & Wallace, D. C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.20.7952 · Cited by 505 · see citing works

Isolated Cerebral and Cerebellar Mitochondria Produce Free Radicals when Exposed to Elevated Ca2+ and Na+: Implications for Neurodegeneration

Dykens, J. A. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63020584.x · Cited by 493 · see citing works

Hydrogen peroxide-induced injury of cells and its prevention by inhibitors of poly(ADP-ribose) polymerase.

Schraufstätter, I. U., Hyslop, P. A., Hinshaw, D. B., Spragg, R. G., Sklar, L. A., & Cochrane, C. G. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4908 · Cited by 459 · see citing works

Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity

Przedborski, S., Kostić, V., Jackson-Lewis, V. R., Naini, A. B., Simonetti, S., Fahn, S., Carlson, E. J., Epstein, C. J., & Cadet, J. (1992) · Journal of Neuroscience · doi:10.1523/jneurosci.12-05-01658.1992 · Cited by 456 · see citing works

BRAIN, SKELETAL MUSCLE AND PLATELET HOMOGENATE MITOCHONDRIAL FUNCTION IN PARKINSON'S DISEASE

MANN, V. M., COOPER, J. M., KRIGE, D., DANIEL, S. E., SCHAPIRA, A. H. V., & MARSDEN, C. D. (1992) · Brain · doi:10.1093/brain/115.2.333 · Cited by 346 · see citing works

Involvement of Free Radicals in Excitotoxicity In Vivo

Schulz, J. B., Henshaw, D. R., Siwek, D. F., Jenkins, B. G., Ferrante, R. J., Cipolloni, P. B., Kowall, N. W., Rosen, B. R., & Beal, M. F. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64052239.x · Cited by 322 · see citing works

Kynurenine Pathway Measurements in Huntington's Disease Striatum: Evidence for Reduced Formation of Kynurenic Acid

Beal, M. F., Matson, W. R., Swartz, K. J., Gamache, P. H., & Bird, E. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb03143.x · Cited by 312 · see citing works

Age‐Dependent Striatal Excitotoxic Lesions Produced by the Endogenous Mitochondrial Inhibitor Malonate

Beal, M. F., Brouillet, E., Jenkins, B. G., Henshaw, R., Rosen, B. R., & Hyman, B. T. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03633.x · Cited by 297 · see citing works

Rapid ATP Loss Caused by 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine in Mouse Brain

Chan, P., DeLanney, L. E., Irwin, I., Langston, J. W., & Monte, D. A. D. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb02134.x · Cited by 241 · see citing works

Intracranial microdialysis of salicylic acid to detect hydroxyl radical generation through dopamine autooxidation in the caudate nucleus: Effects of MPP+

Chiueh, C. C., Krishna, G. A., Tulsi, P., et al. (1992) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(92)90151-6 · Cited by 235 · see citing works

Interaction of 1‐Methyl‐4‐Phenylpyridinium Ion (MPP+) and Its Analogs with the Rotenone/Piericidin Binding Site of NADH Dehydrogenase

Ramsay, R. R., Krueger, M. J., Youngster, S. K., et al. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb11409.x · Cited by 211 · see citing works

Coenzyme Q₁₀ and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate

Beal, M. F., Henshaw, D. R., Jenkins, B. G., Rosen, B. R., & Schulz, J. B. (1994) · Annals of Neurology · doi:10.1002/ana.410360613 · Cited by 189 · see citing works

1‐Methyl‐4‐Phenylpyridinium Produces Excitotoxic Lesions in Rat Striatum as a Result of Impairment of Oxidative Metabolism

Storey, E., Hyman, B. T., Jenkins, B. G., Brouillet, E., Miller, J. M., Rosen, B. R., & Beal, M. F. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10080.x · Cited by 164 · see citing works

Chemically induced hypoglycemia and anoxia: relationship to glutamate receptor-mediated toxicity in retina.

Zeevalk, G. D., & Nicklas, W. J. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13234-5 · Cited by 164 · see citing works

MK‐801 Prevents 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine‐Induced Parkinsonism in Primates

Zuddas, A., Oberto, G., Vaglini, F., Fascetti, F., Fornai, F., & Corsini, G. U. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09429.x · Cited by 154 · see citing works

Coenzyme Q 10 with multiple vitamins is generally ineffective in treatment of mitochondrial disease

Matthews, P. M., Ford, B., Dandurand, R. J., Eidelman, D. H., O'Connor, D., Sherwin, A. L., Karpati, G., Andermann, F., & Arnold, D. L. (1993) · Neurology · doi:10.1212/wnl.43.5.884 · Cited by 125 · see citing works

MELAS syndrome with mitochondrial tRNA Leu[UUR] mutation

Penn, A. M. W., Lee, J. W. K., Thuillier, P., Wagner, M., Maclure, K. M., Menard, M. R., Hall, L. D., & Kennaway, N. G. (1992) · Neurology · doi:10.1212/wnl.42.11.2147 · Cited by 124 · see citing works

Lateral diffusion of ubiquinone during electron transfer in phospholipid- and ubiquinone-enriched mitochondrial membranes.

Schneider, H., Lemasters, J. J., & Hackenbrock, C. R. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)33893-6 · Cited by 110 · see citing works

Therapy of mitochondrial disorders

Przyrembel, H. (1987) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01812853 · Cited by 102 · see citing works

Ubiquinone Protects Cultured Neurons against Spontaneous and Excitotoxin-Induced Degeneration

Favit, A., Nicoletti, F., Scapagnini, U., & Canonico, P. L. (1992) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1992.88 · Cited by 98 · see citing works

Mitochondrial dysfunction in movement disorders

Schulz, J. B., & Beal, M. F. (1994) · Current Opinion in Neurology · doi:10.1097/00019052-199408000-00010 · Cited by 92 · see citing works

The competitive NMDA antagonist CPP protects substantia nigra neurons from MPTP-induced degeneration in primates

Lange, K. W., L�schmann, P.-A., Sofic, E., et al. (1993) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00167234 · Cited by 82 · see citing works

Marked reduction in CSF lactate and pyruvate levels after CoQ therapy in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS)

Abe, K., Fujimura, H., Nishikawa, Y., Yorifuji, S., Mezaki, T., Hirono, N., Nishitani, N., & Kameyama, M. (1991) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1991.tb03962.x · Cited by 76 · see citing works

A protective effect of coenzyme Q10 on ischemia and reperfusion of the isolated perfused rat heart

Ohhara, H. (1981) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(81)90229-7 · Cited by 74 · see citing works

Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine

Klivenyi, P., Andreassen, O. A., Ferrante, R. J., Dedeoglu, A., Mueller, G., Lancelot, E., Bogdanov, M., Andersen, J. K., Jiang, D., & Beal, M. F. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-01-00001.2000 · Cited by 1,111 · see citing works

Coenzyme Q ₁₀ administration increases brain mitochondrial concentrations and exerts neuroprotective effects

Matthews, R. T., Yang, L., Browne, S., Baik, M., & Beal, M. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8892 · Cited by 557 · see citing works

Mitochondrial Approaches for Neuroprotection

Chaturvedi, R. K., & Beal, M. F. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.027 · Cited by 294 · see citing works

Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice

Beal, M. F., Matthews, R. T., Tieleman, A., & Shults, C. W. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01192-x · Cited by 256 · see citing works

Dual Effects of Antioxidants in Neurodegeneration: Direct Neuroprotection against Oxidative Stress and Indirect Protection via Suppression of Gliamediated Inflammation

Wang, J.-Y., Wen, L. L., Huang, Y.-N., Chen, Y.-T., & Ku, M.-C. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206778343109 · Cited by 250 · see citing works

Bioenergetic approaches for neuroprotection in Parkinson's disease

Beal, M. F. (2003) · Annals of Neurology · doi:10.1002/ana.10479 · Cited by 236 · see citing works

Nmnat delays axonal degeneration caused by mitochondrial and oxidative stress

Press, C., & Milbrandt, J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0525-08.2008 · Cited by 137 · see citing works

Q10 therapy in patients with idiopathic Parkinson's disease

Strijks, E., Kremer, H. P. H., & Horstink, M. W. I. M. (1997) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(97)00008-3 · Cited by 45 · see citing works

Neuroprotective Effect of Coenzyme Q10 in Hippocampal Injury in Balb/c Mouse

Rigi, S., Sakhaei, A., Asl, A. N., et al. (2014)

Coenzyme Q10 in the central nervous system and its potential usefulness in the treatment of neurodegenerative diseases

Beal, M. F., & Matthews, R. T. (1997) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(97)00024-1 · Cited by 58 · see citing works

Dose-dependent Effects of Bee Venom Acupuncture on MPTP-induced Mouse Model of Parkinson’s Disease

Jun, H., & Kim, Y. S. (2010) · Cited by 3 · see citing works

MPTP 유발 파킨슨 병 동물 모델에서의 신수혈(BL23) 봉독약침의 항염증 효과

김찬영, 이재동, 이상훈, et al. (2009) · 대한침구학회지

Heart Failure—Do We Need New Drugs or Have Them Already? A Case of Coenzyme Q10

Filipiak, K. J., Surma, S., Romańczyk, M., & Okopień, B. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9050161 · Cited by 5 · see citing works